EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracellular Vesicles Analysis as Possible Signatures of Antiphospholipid Syndrome Clinical Features

Giulio Luigi Bonisoli, Giuseppe Argentino iD, Simonetta Friso iD, Elisa Tinazzi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26072834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Giulio Luigi Bonisoli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Verona, 37134 Verona, Italy. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Extracellular Vesicles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiphospholipid syndrome (APS) is a rare autoimmune disease characterized by thrombosis and obstetric complications. Extracellular vesicles (EVs) of either platelet and endothelial origin are recognized to be involved in the pathophysiology of the disease. This study aimed to evaluate the potential role of endothelial- and platelet-derived extracellular vesicles and the clinical features or progression of APS. We enrolled 22 patients diagnosed with APS and 18 age and sex-matched healthy controls. We determined APS-specific antibody positivity and clinical manifestations in APS affected patients, with a focus on neurological, cardiovascular, dermatological, hematological manifestations, and pregnancy-related complications. Platelet-poor plasma was collected from either patients and controls for the analysis of EVs by flow cytometry technology using monoclonal antibodies to specifically identify those derived from either platelets and/or endothelial cells. EVs of endothelial and platelet origins were overall significantly increased in patients as compared to healthy controls. Furthermore, a significant association was also observed between the number of extracellular vesicles and specific organ involvement, particularly central nervous system manifestations, hematological abnormalities, and obstetric complications. An elevated proportion of endothelial-derived EVs in APS and a reduction of resting endothelial cell-derived EVs were observed in APS-affected women with obstetric complications. Our findings highlight the involvement of endothelial cells and platelets in mirroring the activities of endothelial cells and platelets in APS. Additionally, extracellular vesicles may serve as potential predictors of organ involvement and disease-related damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromeExtracellular VesiclesHumansFemaleAdultMiddle AgedMalePregnancyEndothelial CellsBlood PlateletsCase-Control StudiesBiomarkersAntibodies, Antiphospholipid

Stichwörter der Autor:innen

CD146CD42aannexin Vantiphospholipid syndromeendothelial damageextracellular vesiclesorgan involvement

Substanzen

BiomarkersAntibodies, Antiphospholipid

Autor:innen und Institutionen

  • Department of Medicine, University of Verona, 37134 Verona, Italy.

ORCID-Profile: Giuseppe Argentino, Simonetta Friso, Elisa Tinazzi

Zitieren

APA

Bonisoli, G. L., Argentino, G., Friso, S., & Tinazzi, E. (2025). Extracellular Vesicles Analysis as Possible Signatures of Antiphospholipid Syndrome Clinical Features. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072834

Vancouver

Bonisoli GL, Argentino G, Friso S, Tinazzi E. Extracellular Vesicles Analysis as Possible Signatures of Antiphospholipid Syndrome Clinical Features. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072834

BibTeX
@article{Bonisoli2025,
  author = {Bonisoli, Giulio Luigi and Argentino, Giuseppe and Friso, Simonetta and Tinazzi, Elisa},
  title = {Extracellular Vesicles Analysis as Possible Signatures of Antiphospholipid Syndrome Clinical Features},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26072834}
}
Kostenlos starten →